Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development

ABSTRACT SARS-CoV-2 poses an ongoing threat to human health as variants continue to emerge. Several effective vaccines are available, but a diminishing number of Americans receive the updated vaccines (only 22% received the 2023 update). Public hesitancy towards vaccines and common occurrence of “br...

Полное описание

Библиографические подробности

Главные авторы:	Ariel J. Kuhn, Victor K. Outlaw, Tara C. Marcink, Zhen Yu, Megan C. Mears, Maria N. Cajimat, Dale F. Kreitler, Payton R. Cleven, Jee Ching Mook, Dennis A. Bente, Matteo Porotto, Samuel H. Gellman, Anne Moscona
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology 2025-03-01
Серии:	Journal of Virology
Предметы:	SARS-CoV-2 lipopeptide solubility inhibitors viral fusion heptad repeats
Online-ссылка:	https://journals.asm.org/doi/10.1128/jvi.02159-24
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!